All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know ALL.
Now you can personalise
your ALL Hub experience!
Bookmark content to read later
Select your specific areas of interest
View content recommended for youFind out more
Monoclonal antibodies target antigens expressed predominantly by leukemic cells, making them more selective than chemotherapy. Antibodies induce an immune response to destroy cancer cells, or block key extracellular sites such as receptors to induce cancer cell death. The therapeutic potential of targeting CD19, CD22, or CD33 might vary according to age and ALL subtype.
Save to your areas of interest